SCHEMBL5525488

SCHEMBL5525488

CCN(C)C(=O)c1cc(-c2ccc(CNC(=O)N3CCOCC3)cn2)n(-c2ccc(C)nc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.40
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
MLLT1 Q03111 2/20 0.36
TGFBR1 P36897 1/20 0.35
PDK1 Q15118 1/20 0.35
VNN1 O95497 2/20 0.35
PTGS2 P35354 2/20 0.34
MEN1 O00255 3/20 0.34
MAPT P10636 3/20 0.34
KMT2A Q03164 3/20 0.34
TNF P01375 1/20 0.34
MAPK14 Q16539 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5533378 0.92 MEN1 (0.41) NAMPTMLLT1PDK1MEN1KMT2A
SCHEMBL5516440 0.89 GLS (0.36) NAMPTMLLT1VNN1P2RY12KIT
SCHEMBL5524209 0.87 PIK3CA (0.35) NAMPT
SCHEMBL5530272 0.86 WDR5 (0.34) NAMPT
SCHEMBL5525372 0.85 MALT1 (0.35) NAMPT
SCHEMBL5979134 0.85 NAMPT (0.35) NAMPT
SCHEMBL14416571 0.85 RPA1 (0.36) SMN1; SMN2ALDH1A1
SCHEMBL5520734 0.83 SMO (0.39) NAMPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL5521080 0.82 MLLT1 (0.49) MLLT1MEN1KMT2AP2RY12KIT
SCHEMBL5517681 0.81 MALT1 (0.35) NAMPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 NAMPT 2905/4885NOS3 260/4885NOS1 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.